全球癫痫治疗市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球癫痫治疗市场 – 行业趋势及 2029 年预测

  • Healthcare
  • Upcoming Report
  • Oct 2024
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Epilepsy Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 6.50 Million
Diagram Market Size (Forecast Year)
USD 2.43 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Pfizer
  • Novartis AG
  • Abbott
  • Neurelis
  • GSK plc

>全球癫痫治疗市场,按病症(癫痫耐药/难治性癫痫、其他)、药物(第一代、第二代、第三代)、分销渠道(医院、诊所、零售药店、网上药店)、最终用户(医院、诊所、门诊手术中心、诊断中心)划分 - 行业趋势和预测至 2029 年。

癫痫治疗市场

癫痫治疗市场分析及规模

据世界卫生组织报告,2017年全球人均医疗总费用为1,064.741美元。全球人均医疗费用从2008年的864.313美元增加到2018年的1,110.841美元,其中美国是最高支付国,2018年人均医疗费用为10,623.85美元。美国国内政府一般医疗支出从2008年的3515.82美元增加到2018年的5355.79美元。这些只是近年来推动市场扩张的一些因素。

Data Bridge Market Research 分析,癫痫治疗市场规模在 2021 年为 13.3053 亿美元,到 2029 年将飙升至 21.5288 亿美元,预计在 2022 年至 2029 年的预测期内复合年增长率为 6.20%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

癫痫治疗市场范围和细分      

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020(可定制为 2014 - 2019)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

病情(癫痫耐药/难治性癫痫,其他)、药物(第一代、第二代、第三代)、分销渠道(医院、诊所、零售药店、网上药店)、最终用户(医院、诊所、门诊手术中心、诊断中心)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、欧洲的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Pfizer Inc. (U.S.), Novartis AG (Germany), Abbott (U.S.), Neurelis Inc. (U.S.), GSK plc (U.K.), Johnson & Johnson Services Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (U.S.), Sumitomo Dainippon Pharma Co. Ltd (Japan), Bausch Health Companies Inc. (Canada), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), UCB S.A. (China), Marinus Pharmaceuticals Inc. (U.S.), Eisai Co. Ltd (Japan), H. Lundbeck A/S (Denmark), Supernus Pharmaceuticals Inc (U.S.), DAIICHI SANKYO COMPANY LIMITED (Japan)

Market Opportunities

  • Growing demand for treatment for neurological diseases
  • Decreasing social stigma regarding epilepsy

Market Definition

The term "epilepsy" describes a long-term neurological condition that results in frequent, unjustified seizures. A person with epilepsy frequently experiences seizures that have no known cause. The actual origins of these seizures are yet unknown, but they may be brought by some stressful event or a prior brain injury. The disorder often affects both adults and children, however the danger of infection is higher in the elderly population.

Epilepsy Treatment Market Dynamics

Drivers

  • Rise in injuries

The key drivers driving the epilepsy treatment market are the rise in accidents and brain injuries and the high rates of post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) occurrence in patients with brain injuries. The expansion of the epilepsy treatment market is accelerated by the rise in government funding for improving and developing effective medications and treatments for seizures, as well as the rise in R&D activities to provide cutting-edge healthcare facilities.

  • Technological advancements

The market for epilepsy treatments is also impacted by groups working together to provide physicians and the public with better treatment options and awareness training initiatives.

  • Rise in the geriatric population

The ageing population, rising epilepsy rates, increased public awareness of treatment alternatives, and declining treatment costs all favor the market. The development of new medications and therapeutic options and the approval and introduction of new products provide lucrative opportunities to the players in the epilepsy treatment market during the forecast period of 2022 to 2029. market for treating epilepsy.

Opportunities

  • Increase in the number of research and development activities 

The initiatives by the government and advancement in drugs and treatments across the globe are escalating the growth of epilepsy treatment market.

Restraints/Challenges

On the other hand, lack of affordability and emergence of epilepsy therapeutic methods in the developing nations are factors expected to obstruct the epilepsy treatment market.

本癫痫治疗市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关癫痫治疗市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

COVID-19 对癫痫治疗市场的影响

疫情干扰了神经病学活动,例如医学培训和研究。癫痫治疗机构以及癫痫患者都受到了 COVID-19 的社会影响。由于 SARS-CoV-2 有可能在患者之间或医护人员之间传播,患者前往医疗机构的机会受到了严重限制。此外,由于担心患者之间传播,在有 COVID-19 住院患者的医院或 COVID-19 疫情广泛传播的地区,候补入院人数也受到了严重限制。

近期发展

  • 2021年8月,在柳柳制药与韩国诺华签署的协议中,柳柳获得了三种处方药的独家经销权,其中包括Tegretol,一种含有卡马西平药物的药物,用于治疗癫痫等疾病。
  • 2021 年 2 月,领先的远程诊断和监控提供商 BioTelemetry, Inc. 被荷兰皇家飞利浦公司收购

全球癫痫治疗市场范围

癫痫治疗市场根据病情、药物、分销渠道和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

健康)状况

  • 癫痫 药物耐药性/难治性癫痫
  • 其他的

 药品

  • 第一代
  • 第二代
  • 第三代

分销渠道

  • 医院
  •  诊所
  • 零售药店
  • 网上药店

最终用户

癫痫治疗市场区域分析/见解

对癫痫治疗市场进行了分析,并按国家、条件、药物、分销渠道和最终用户提供了市场规模洞察和趋势。

癫痫治疗市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于政府为改善医疗保健体系而采取的有利举措,北美在癫痫治疗市场占据主导地位。

由于政府资金增加以及对改善治疗设施的支持(尤其是在新兴经济体中),预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和癫痫治疗市场份额分析

癫痫治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对癫痫治疗市场的关注有关。

癫痫治疗市场的一些主要参与者包括:

  • 辉瑞公司(美国)
  • 诺华公司(德国)
  • 雅培(美国)
  • Neurelis Inc.(美国)
  • 葛兰素史克公司 (英国)
  • 强生服务公司 (美国)
  • Teva Pharmaceutical Industries Ltd.(美国)
  • 住友大日本制药有限公司 (日本)
  • Bausch Health Companies Inc.(加拿大)
  • 赛诺菲(法国)
  • 武田药品工业株式会社 (日本)
  • 优时比集团(中国)
  • Marinus Pharmaceuticals Inc.(美国)
  • 卫材株式会社 (日本)
  • H. Lundbeck A/S(丹麦)
  • Supernus Pharmaceuticals Inc(美国)
  • 第一三共株式会社(日本)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Segmentation, By Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), Drug (First-Generation, Second-Generation, Third-Generation), Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers) – Industry Trends and Forecast to 2031 .
The Global Epilepsy Treatment Market size was valued at USD 6.50 USD Million in 2023.
The Global Epilepsy Treatment Market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2031.
The major players operating in the market include Pfizer , Novartis AG, Abbott, Neurelis , GSK plc, Johnson & Johnson Services , Teva Pharmaceutical Industries , Sumitomo Dainippon Pharma Co. Ltd, Bausch Health Companies , Sanofi, Takeda Pharmaceutical Company Limited, UCB S.A., Marinus Pharmaceuticals , Eisai Co. Ltd, H. Lundbeck A/S, Supernus Pharmaceuticals , DAIICHI SANKYO COMPANY LIMITED.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.